CDTVSRXRX• 28 Days (Normalized)
CDT vs RXRX (CDT Equity Inc. vs Recursion Pharmaceuticals Inc.)
Showing Closing Date Range from Sep 10 to Oct 8, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CDT Performance $0.8
-90.72%
CDT Equity Inc.
Normalized Baseline0.00%
RXRX Performance $3.95
+25%
Recursion Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin RXRX LEADS
-115.72 pts
RXRX outperforming by 115.72 percentage points
CDTRXRX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CDT RXRX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | CDT Price | CDT Gain (%) | RXRX Price | RXRX Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 08, 2026 | $0.80 | -90.72% | $3.95 | +25.00% | -115.72% |
| Oct 07, 2026 | $0.84 | -90.31% | $4.27 | +35.13% | -125.44% |
| Oct 06, 2026 | $0.93 | -89.22% | $4.63 | +46.52% | -135.74% |
| Oct 05, 2026 | $0.92 | -89.36% | $4.78 | +51.27% | -140.63% |
| Oct 02, 2026 | $0.99 | -88.52% | $4.12 | +30.38% | -118.90% |
| Oct 01, 2026 | $1.25 | -85.51% | $4.07 | +28.80% | -114.31% |
| Sep 30, 2026 | $1.36 | -84.23% | $4.13 | +30.70% | -114.93% |
| Sep 29, 2026 | $1.45 | -83.19% | $4.03 | +27.53% | -110.72% |
| Sep 28, 2026 | $1.90 | -77.97% | $3.70 | +17.09% | -95.06% |
| Sep 25, 2026 | $2.00 | -76.81% | $3.74 | +18.35% | -95.16% |
| Sep 24, 2026 | $3.03 | -64.93% | $3.89 | +23.10% | -88.03% |
| Sep 23, 2026 | $3.38 | -60.87% | $3.70 | +17.09% | -77.96% |
| Sep 22, 2026 | $3.55 | -58.84% | $4.05 | +28.16% | -87.00% |
| Sep 21, 2026 | $3.85 | -55.36% | $3.97 | +25.63% | -80.99% |
| Sep 18, 2026 | $4.35 | -49.57% | $3.83 | +21.20% | -70.77% |
Page 1 of 2